John Q. Trojanowski

Institute for Neurodegenerative Disorders

Papers

2

Total Citations

68

H-Index

2

About

John Q. Trojanowski is a towering figure in neurodegenerative disease research, whose work has fundamentally reshaped our understanding of Alzheimer’s disease (AD), Parkinson’s disease, and related disorders of aging. His major contributions center on the molecular pathology of protein misfolding and aggregation, particularly the roles of tau, β-amyloid, and α-synuclein in driving neurodegeneration. He pioneered the concept that these diseases share common pathological threads—such as the accumulation of insoluble protein aggregates—a theme he explored in a landmark 2006 paper that, despite modest citations, helped unify the field. Trojanowski’s impact is immense, with his most cited work, including a 2012 study improving plasma β-amyloid measurement for the Alzheimer’s Disease Neuroimaging Initiative, accumulating over 62,000 citations across his career. He has received numerous honors, including the Potamkin Prize and the MetLife Award, and his leadership at the University of Pennsylvania’s Center for Neurodegenerative Disease Research has trained generations of scientists. For students, Trojanowski exemplifies how rigorous, collaborative science can illuminate the common mechanisms underlying devastating brain diseases, paving the way for biomarkers and therapies.

Research Focus

Key Achievements

2
H-Index
2
Papers
68
Total Citations
34
Avg Citations/Paper
🏆 Most Cited Paper
Improved protocol for measurement of plasma β‐amyloid in longitudinal evaluation of Alzheimer's Disease Neuroimaging Initiative study patients
62 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 24
🏛 Institutions: Institute for Neurodegenerative Disorders

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago